Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProBCG: BCG Vaccine for COVID-19 Prevention in Health Care Workers
NCT04659941Phase 2Unknown
- Sponsor
- Federal University of Rio de Janeiro
- Start
- Oct 2020
- Primary completion
- Oct 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of bcg vaccine in coronavirus disease 2019 (COVID-19), sponsored by Federal University of Rio de Janeiro. Status: unknown.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04659941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04659941.